Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
M.D. Anderson Cancer Center
Maastricht University Medical Center
MedSIR
Memorial Sloan Kettering Cancer Center
Tianjin Medical University Cancer Institute and Hospital
University of Pittsburgh
Zhejiang Cancer Hospital
Stanford University
Sun Yat-sen University
University of Kentucky
Latin American Cooperative Oncology Group
Sun Yat-sen University
Wake Forest University Health Sciences
Fudan University
Yale University
Apollomics Inc.
City of Hope Medical Center
Maastricht University Medical Center
Fundación GECP
Sun Yat-sen University
Sun Yat-sen University
British Columbia Cancer Agency
Dana-Farber Cancer Institute
Fudan University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Centre hospitalier de l'Université de Montréal (CHUM)
Maastricht University Medical Center
Memorial Sloan Kettering Cancer Center
Taizhou Hospital
Hoosier Cancer Research Network
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Albert Einstein College of Medicine
Second Affiliated Hospital of Nanchang University
Sun Yat-sen University
Stanford University
Eastern Cooperative Oncology Group
Sun Yat-sen University
Duke University
Genentech, Inc.
University of Colorado, Denver
Duke University
Seoul St. Mary's Hospital
M.D. Anderson Cancer Center
Soroka University Medical Center
Sun Yat-sen University
Chongqing University Cancer Hospital
Yale University
University of Pittsburgh